MASTER SERVICES AGREEMENT
 
This Master Services Agreement (the “Agreement”) is entered into as of April 27th, 2015 (the “Effective Date”) by and between Accelerated Pharma Inc. with a place of business at 15W15581st, Burr Ridge 60527 Illinois, USA (“Accelerated”), and Heraeus Precious Metals GmbH & Co. KG, a German limited liability company with a principal place of business located at Heraeusstr. 12- 14, 63450 Hanau, Germany (“Manufacturer” or “Heraeus”), each singly a “Party” and together, the “Parties.”
 
RECITALS
 
Accelerated intends to entrust Heraeus with the manufacture of the active pharmaceutical ingredient Picoplatin which is required by Accelerated for a clinical development program.
 
NOW, THEREFORE, the Parties agree as follows: